These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 21663445)
21. Intravenous methylprednisolone in treatment of traumatic optic neuropathy. Chen HY; Tsai RK; Wang HZ Kaohsiung J Med Sci; 1998 Sep; 14(9):577-83. PubMed ID: 9796202 [TBL] [Abstract][Full Text] [Related]
22. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss. Arslan N; Oğuz H; Demirci M; Şafak MA; İslam A; Kaytez SK; Samim E Otol Neurotol; 2011 Apr; 32(3):393-7. PubMed ID: 21221047 [TBL] [Abstract][Full Text] [Related]
23. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344 [TBL] [Abstract][Full Text] [Related]
24. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris. Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids]. Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418 [TBL] [Abstract][Full Text] [Related]
26. Comparison of peripapillary retinal nerve fiber layer loss and visual outcome in fellow eyes following sequential bilateral non-arteritic anterior ischemic optic neuropathy. Dotan G; Kesler A; Naftaliev E; Skarf B Curr Eye Res; 2015 May; 40(6):632-7. PubMed ID: 25153943 [TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A Retina; 2006; 26(9):999-1005. PubMed ID: 17151486 [TBL] [Abstract][Full Text] [Related]
28. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study. Grenga P; Lupo S; Domanico D; Vingolo EM Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938 [TBL] [Abstract][Full Text] [Related]
30. Visual outcome of patients following NAION after treatment with adjunctive fluocortolone. Prokosch V; Thanos S Restor Neurol Neurosci; 2014; 32(3):381-9. PubMed ID: 24225379 [TBL] [Abstract][Full Text] [Related]
31. Severe visual loss by inhalation of methanol. Figuerola B; Mendoza A; Roca M; Lacorzana J Rom J Ophthalmol; 2021; 65(2):176-179. PubMed ID: 34179584 [No Abstract] [Full Text] [Related]
33. Functional and anatomic response of the retina and the choroid to intravitreal bevacizumab for macular edema. Forte R; Cennamo G; Breve MA; Vecchio EC; de Crecchio G J Ocul Pharmacol Ther; 2012 Feb; 28(1):69-75. PubMed ID: 22059904 [TBL] [Abstract][Full Text] [Related]
34. Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months. Lasave AF; Díaz-Llopis M; Muccioli C; Belfort R; Arevalo JF Ophthalmology; 2010 Sep; 117(9):1831-8. PubMed ID: 20471684 [TBL] [Abstract][Full Text] [Related]
35. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Zucchiatti I; Lattanzio R; Querques G; Querques L; Del Turco C; Cascavilla ML; Bandello F Ophthalmologica; 2012; 228(2):117-22. PubMed ID: 22310491 [TBL] [Abstract][Full Text] [Related]
37. Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification. Meacock WR; Spalton DJ; Bender L; Antcliff R; Heatley C; Stanford MR; Graham EM Br J Ophthalmol; 2004 Sep; 88(9):1122-4. PubMed ID: 15317700 [TBL] [Abstract][Full Text] [Related]
38. Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Blumenkranz MS; Haller JA; Kuppermann BD; Williams GA; Ip M; Davis M; Weinberg DV; Chou C; Whitcup SM Retina; 2010; 30(7):1090-4. PubMed ID: 20616686 [TBL] [Abstract][Full Text] [Related]
39. Vitreopapillary traction in eyes with idiopathic epiretinal membrane: a spectral-domain optical coherence tomography study. Kim YW; Jeoung JW; Yu HG Ophthalmology; 2014 Oct; 121(10):1976-82. PubMed ID: 24880904 [TBL] [Abstract][Full Text] [Related]
40. One-year outcomes of less frequent bevacizumab in age-related macular degeneration. Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]